Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Correction to: Ibalizumab: First Global Approval

Correction to: Ibalizumab: First Global Approval Drugs (2018) 78:859 https://doi.org/10.1007/s40265-018-0926-2 CORRECTION Anthony Markham Published online: 30 May 2018 Springer Nature 2018 Correction to: Drugs 78(7):781–785 (2018) any noncommercial use, duplication, adaptation, distribu- https://doi.org/10.1007/s40265-018-0907-5 tion and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the The article Ibalizumab: First Global Approval, written by source, provide a link to the Creative Commons license and Anthony Markham, was originally published Online First indicate if changes were made. without open access. After publication in volume 78, issue The original article was corrected. 7, pages 781–785 Theratechnologies Inc. requested that the Open Access This article is distributed under the terms of the article be Open Choice to make the article an open access Creative Commons Attribution-NonCommercial 4.0 International publication. Post-publication open access was funded by License (http://creativecommons.org/licenses/by-nc/4.0/), which per- Theratechnologies Inc. The article is forthwith distributed mits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appro- under the terms of the Creative Commons Attribution- priate credit to the original author(s) and the source, provide a link to NonCommercial 4.0 International License (http:// the Creative Commons license and indicate if changes were made. creativecommons.org/licenses/by-nc/4.0/), which permits The original article can be found online at https://doi.org/10.1007/ s40265-018-0907-5. & Anthony Markham [email protected] Springer, Private Bag 65901, Mairangi Bay, 0754 Auckland, New Zealand http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drugs Springer Journals

Correction to: Ibalizumab: First Global Approval

Markham, Anthony
Drugs , Volume 78 (8) – May 30, 2018
Download PDF
1 page

Loading next page...
 
/lp/springer_journal/correction-to-ibalizumab-first-global-approval-R3S02Umx48

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Nature
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
0012-6667
eISSN
1179-1950
DOI
10.1007/s40265-018-0926-2
Publisher site
See Article on Publisher Site

Abstract

Drugs (2018) 78:859 https://doi.org/10.1007/s40265-018-0926-2 CORRECTION Anthony Markham Published online: 30 May 2018 Springer Nature 2018 Correction to: Drugs 78(7):781–785 (2018) any noncommercial use, duplication, adaptation, distribu- https://doi.org/10.1007/s40265-018-0907-5 tion and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the The article Ibalizumab: First Global Approval, written by source, provide a link to the Creative Commons license and Anthony Markham, was originally published Online First indicate if changes were made. without open access. After publication in volume 78, issue The original article was corrected. 7, pages 781–785 Theratechnologies Inc. requested that the Open Access This article is distributed under the terms of the article be Open Choice to make the article an open access Creative Commons Attribution-NonCommercial 4.0 International publication. Post-publication open access was funded by License (http://creativecommons.org/licenses/by-nc/4.0/), which per- Theratechnologies Inc. The article is forthwith distributed mits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appro- under the terms of the Creative Commons Attribution- priate credit to the original author(s) and the source, provide a link to NonCommercial 4.0 International License (http:// the Creative Commons license and indicate if changes were made. creativecommons.org/licenses/by-nc/4.0/), which permits The original article can be found online at https://doi.org/10.1007/ s40265-018-0907-5. & Anthony Markham [email protected] Springer, Private Bag 65901, Mairangi Bay, 0754 Auckland, New Zealand

Journal

Drugs – Springer Journals

Published: May 30, 2018

There are no references for this article.